ZBD(SH:603567) Sou Hu Cai Jing·2025-07-29 15:04Group 1 - The core viewpoint of the news is that Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. has experienced significant declines in revenue and net profit in its latest quarterly report, indicating potential challenges for the company [1] - As of July 29, 2025, Zhenbaodao's stock closed at 12.4 yuan, down 2.21%, with a trading volume of 182,700 hands and a transaction amount of 227 million yuan [1] - The company's latest quarterly report shows total operating revenue of 469 million yuan, a year-on-year decrease of 58.03%, and a net profit attributable to shareholders of 75.3 million yuan, a year-on-year decrease of 74.33% [1] Group 2 - The company has a current ratio of 2.300, a quick ratio of 1.770, and a debt-to-asset ratio of 34.99%, indicating a relatively stable liquidity position [1] - Zhenbaodao has made investments in 27 enterprises and participated in 2,123 bidding projects, showcasing its active engagement in the market [2] - The company holds 133 trademark registrations and 204 patents, along with 229 administrative licenses, reflecting its commitment to intellectual property and regulatory compliance [2]